DK1051170T3 - Anvendelse af substituerede aminomethyl-chromaner til forebyggelse af nervedegeneration og til fremskyndelse af nerveregeneration - Google Patents

Anvendelse af substituerede aminomethyl-chromaner til forebyggelse af nervedegeneration og til fremskyndelse af nerveregeneration

Info

Publication number
DK1051170T3
DK1051170T3 DK98961174T DK98961174T DK1051170T3 DK 1051170 T3 DK1051170 T3 DK 1051170T3 DK 98961174 T DK98961174 T DK 98961174T DK 98961174 T DK98961174 T DK 98961174T DK 1051170 T3 DK1051170 T3 DK 1051170T3
Authority
DK
Denmark
Prior art keywords
nerve
chromas
prevention
accelerate
substituted aminomethyl
Prior art date
Application number
DK98961174T
Other languages
Danish (da)
English (en)
Inventor
Thomas Fahrig
Irene Gerlach
Reinhard Jork
Ervin Horvath
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK1051170T3 publication Critical patent/DK1051170T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK98961174T 1997-11-24 1998-11-11 Anvendelse af substituerede aminomethyl-chromaner til forebyggelse af nervedegeneration og til fremskyndelse af nerveregeneration DK1051170T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751949A DE19751949A1 (de) 1997-11-24 1997-11-24 Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
PCT/EP1998/007197 WO1999026621A1 (de) 1997-11-24 1998-11-11 Verwendung von substituierten aminomethyl-chromanen zur verhinderung der neuronalen degeneration und zur förderung der neuronalen regeneration

Publications (1)

Publication Number Publication Date
DK1051170T3 true DK1051170T3 (da) 2001-12-27

Family

ID=7849618

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98961174T DK1051170T3 (da) 1997-11-24 1998-11-11 Anvendelse af substituerede aminomethyl-chromaner til forebyggelse af nervedegeneration og til fremskyndelse af nerveregeneration

Country Status (30)

Country Link
US (2) US6235774B1 (https=)
EP (1) EP1051170B1 (https=)
JP (1) JP2001523716A (https=)
KR (1) KR20010032357A (https=)
CN (1) CN1134256C (https=)
AR (1) AR016973A1 (https=)
AT (1) ATE206615T1 (https=)
AU (1) AU745759B2 (https=)
BG (1) BG64167B1 (https=)
CA (1) CA2311126A1 (https=)
DE (2) DE19751949A1 (https=)
DK (1) DK1051170T3 (https=)
ES (1) ES2164465T3 (https=)
HN (1) HN1998000169A (https=)
HU (1) HUP0004369A3 (https=)
IL (1) IL135904A (https=)
IS (1) IS5496A (https=)
MY (1) MY118414A (https=)
NO (1) NO20002638D0 (https=)
NZ (1) NZ504656A (https=)
PE (1) PE134999A1 (https=)
PL (1) PL340674A1 (https=)
PT (1) PT1051170E (https=)
RU (1) RU2217140C2 (https=)
SI (1) SI1051170T1 (https=)
SV (1) SV1998000138A (https=)
TR (1) TR200001471T2 (https=)
TW (1) TW524690B (https=)
WO (1) WO1999026621A1 (https=)
ZA (1) ZA9810668B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
MXPA02009071A (es) * 2000-03-17 2003-05-23 Alcon Inc Compuestos con actividad agonista de 5-ht 1a para tratar glaucoma..
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
SE0004455D0 (sv) * 2000-12-01 2000-12-01 Milos Pekny Method for neuron regeneration in the central nervous system
DE10101917A1 (de) * 2001-01-16 2002-07-18 Bayer Ag Verwendung von Chromanen
PT1408964E (pt) * 2001-07-26 2007-05-31 Merck Patent Gmbh Utilização de 2-5-(4-fluorofenil) -3-piridilmetilaminometil-cromano e de seus sais fisiologicamente aceitáveis.
ATE341322T1 (de) * 2001-09-12 2006-10-15 Merck Patent Gmbh Verwendung von aminomethyl chromanen zur behandlung der nebenwirkungen von neuroleptika
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
WO2005033093A1 (en) 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives
DE102004017627A1 (de) * 2004-04-10 2005-10-27 Bayer Healthcare Ag Verwendung von vollen 5-HT1A-Agonisten zur Hemmung der opiat/opioid-induzierten Atemdepression
PT3494119T (pt) 2016-07-29 2024-12-10 Pgi Drug Discovery Llc Compostos e composições e seus usos
MA45795A (fr) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc Composés et compositions, et utilisations associées
RU2651756C1 (ru) * 2017-05-10 2018-04-23 Федеральное государственное бюджетное образовательное учреждение Высшего Образования Кубанский Государственный Медицинский Университет Министерства Здравоохранения Российской Федерации, КубГМУ Препарат для предотвращения образования глиальных рубцов
CA3070993C (en) * 2017-08-02 2025-05-20 Sunovion Pharmaceuticals Inc. ISOCHROMANE COMPOUNDS AND THEIR USES
EP3938045A1 (en) 2019-03-14 2022-01-19 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300523A (en) 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE19522088A1 (de) 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration

Also Published As

Publication number Publication date
AR016973A1 (es) 2001-08-01
KR20010032357A (ko) 2001-04-16
HN1998000169A (es) 1999-11-03
SV1998000138A (es) 1999-05-25
WO1999026621A1 (de) 1999-06-03
JP2001523716A (ja) 2001-11-27
EP1051170B1 (de) 2001-10-10
AU1668599A (en) 1999-06-15
IL135904A (en) 2003-07-06
DE19751949A1 (de) 1999-05-27
US6235774B1 (en) 2001-05-22
NO20002638L (no) 2000-05-23
IL135904A0 (en) 2001-05-20
PE134999A1 (es) 2000-03-05
HUP0004369A2 (hu) 2001-04-28
ES2164465T3 (es) 2002-02-16
NO20002638D0 (no) 2000-05-23
ZA9810668B (en) 1999-05-26
CN1134256C (zh) 2004-01-14
IS5496A (is) 2000-05-15
BG64167B1 (bg) 2004-03-31
RU2217140C2 (ru) 2003-11-27
US20010018530A1 (en) 2001-08-30
CA2311126A1 (en) 1999-06-03
EP1051170A1 (de) 2000-11-15
TW524690B (en) 2003-03-21
CN1279604A (zh) 2001-01-10
TR200001471T2 (tr) 2000-10-23
HUP0004369A3 (en) 2002-04-29
PL340674A1 (en) 2001-02-12
NZ504656A (en) 2002-02-01
PT1051170E (pt) 2002-02-28
ATE206615T1 (de) 2001-10-15
BG104466A (en) 2001-02-28
US6331561B2 (en) 2001-12-18
MY118414A (en) 2004-10-30
AU745759B2 (en) 2002-03-28
SI1051170T1 (en) 2001-12-31
DE59801724D1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
DK1051170T3 (da) Anvendelse af substituerede aminomethyl-chromaner til forebyggelse af nervedegeneration og til fremskyndelse af nerveregeneration
NO994506D0 (no) FremgangsmÕter og blandinger for Õ modulere mottagelighet for kortikosteroider
DK0966436T3 (da) Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
DK0785770T3 (da) Sammensætninger til bekæmpelse af hæmorroider og fremgangsmåde til anvendelse deraf
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
ATE297185T1 (de) Verfahren und zusammensetzungen zum bleichen von zähnen
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
FI960809L (fi) Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja
DE69630221D1 (de) Stabile alkoholisch-wässrige zusammensetzung
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
NO20002849L (no) Sammensetninger og metoder for Õ indusere genekspersjon
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
ATE271543T1 (de) N-substituierte 2-cyanopyrrolidine
NO991776L (no) Aminotiofenkarboksylsyreamider og anvendelse derav som fosfodiesteraseinhibitorer
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO20001323L (no) Dipeptid-apoptose-inhibitorer og deres anvendelse
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
DE69605447D1 (de) Verfahren und nichtlineares filter zur verminderung der gleichkanalstörung
EP0883674A4 (en) DISINFECTANT COMPOSITIONS AND METHODS FOR DISINFECTING SURFACES
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
DE69832853D1 (de) Verfahren und Einheit zum kombinierten Übergeben-Wenden von Zigarettenpackungen
DK0902620T3 (da) Midler og fremgangsmåder til bekæmpelse af skadelige svampe
DK0669900T3 (da) Fremgangsmåde til behandling af forbrændingsrester og anvendelsen deraf som adsorptionsmiddel
DE59808967D1 (de) Mittel zum Reinigen von harten Oberflächen
ATE242600T1 (de) Synergitische herbizide verfahren und zusammensetzungen